Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 15/20 | 0.47 |
| ▸ | ITGA4 | P13612 | 15/20 | 0.47 |
| ▸ | ITGA2 | P17301 | 1/20 | 0.43 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.43 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.41 |
| ▸ | LNPEP | Q9UIQ6 | 2/20 | 0.41 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15141210 | 1.00 | ITGB1 (0.47) | ITGB1ITGA4ITGA2ITGB7ERAP2 | |
| Hydrochloric Acid SCHEMBL15141211 | 0.99 | ITGB1 (0.47) | ITGB1ITGA4ITGA2ITGB7ERAP2 | |
| Hydrochloric Acid SCHEMBL15141209 | 0.99 | ITGB1 (0.47) | ITGB1ITGA4ITGA2ITGB7ERAP2 | |
| SCHEMBL4516203 | 0.88 | ITGB1 (0.57) | ITGB1ITGA4ITGA2ITGB7 | |
| SCHEMBL7101344 | 0.88 | ITGB1 (0.57) | ITGB1ITGA4ITGA2ITGB7 | |
| SCHEMBL4516205 | 0.88 | ITGB1 (0.57) | ITGB1ITGA4ITGA2ITGB7 | |
| Hydrochloric Acid SCHEMBL5259160 | 0.87 | ITGB1 (0.56) | ITGB1ITGA4ITGA2ITGB7 | |
| Hydrochloric Acid SCHEMBL5260907 | 0.87 | ITGB1 (0.56) | ITGB1ITGA4ITGA2ITGB7 | |
| SCHEMBL5260189 | 0.86 | ITGB1 (0.61) | ITGB1ITGA4 | |
| SCHEMBL4514318 | 0.86 | ITGB1 (0.61) | ITGB1ITGA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2806897-B1 | INTEGRIN ANTAGONIST CONJUGATES FOR TARGETED DELIVERY TO CELLS EXPRESSING LFA-1 | HOFFMANN LA ROCHE (CH) | 2017-08-02 | — | — | EP | disclosed |
| US-9650363-B2 | Integrin antagonist conjugates for targeted delivery to cells expressing LFA-1 | HOFFMANN-LA ROCHE INC. (US) | 2017-05-16 | — | — | US | disclosed |